ES2155200T3 - Proceso para la preparacion de galantamina y sus derivados. - Google Patents

Proceso para la preparacion de galantamina y sus derivados.

Info

Publication number
ES2155200T3
ES2155200T3 ES96931170T ES96931170T ES2155200T3 ES 2155200 T3 ES2155200 T3 ES 2155200T3 ES 96931170 T ES96931170 T ES 96931170T ES 96931170 T ES96931170 T ES 96931170T ES 2155200 T3 ES2155200 T3 ES 2155200T3
Authority
ES
Spain
Prior art keywords
crushed
compound
galantamine
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96931170T
Other languages
English (en)
Inventor
Robin Mark Bannister
Raymond Mccague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2155200T3 publication Critical patent/ES2155200T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE UN COMPUESTO DE FORMULA (4) O (5), BIEN EN FORMA OPTICAMENTE ENRIQUECIDA O BIEN RACEMICA, SIENDO SELECCIONADOS R 1 , R 2 , R 3 Y R 4 INDEPENDIENTEMENTE A PARTIR DE HIDROGENO, O DE GRUPOS ALQUILO, ARILO, ALCARILO, ARALQUILO Y ACILO. DICHO PROCEDIMIENTO CONSISTE EN MEZCLAR UN PRECURSOR DE CICLACION OXIDATIVA DEL COMPUESTO CITADO CON EL EXTRACTO DE UNA PLANTA.
ES96931170T 1995-09-21 1996-09-23 Proceso para la preparacion de galantamina y sus derivados. Expired - Lifetime ES2155200T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9519268.8A GB9519268D0 (en) 1995-09-21 1995-09-21 Preparation of alkaloids

Publications (1)

Publication Number Publication Date
ES2155200T3 true ES2155200T3 (es) 2001-05-01

Family

ID=10781039

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96931170T Expired - Lifetime ES2155200T3 (es) 1995-09-21 1996-09-23 Proceso para la preparacion de galantamina y sus derivados.

Country Status (12)

Country Link
US (1) US6184004B1 (es)
EP (1) EP0853624B1 (es)
AT (1) ATE199153T1 (es)
AU (1) AU710980B2 (es)
CA (1) CA2230824C (es)
DE (1) DE69611796T2 (es)
DK (1) DK0853624T3 (es)
ES (1) ES2155200T3 (es)
GB (1) GB9519268D0 (es)
GR (1) GR3035752T3 (es)
PT (1) PT853624E (es)
WO (1) WO1997011078A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
EP1181294B1 (de) 2000-03-31 2004-03-31 Sanochemia Pharmazeutika Aktiengesellschaft Neue derivate und analoga von galanthamin
JP4029960B2 (ja) * 2001-10-05 2008-01-09 独立行政法人理化学研究所 アブシジン酸生合成阻害剤
WO2005065662A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
WO2005065661A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galanthamine
EP2316437B1 (en) * 2005-05-13 2014-07-30 Alza Corporation Multilayer drug delivery system with barrier against reservoir material flow
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
AT504663B1 (de) * 2007-02-22 2008-07-15 Sanochemia Pharmazeutika Ag Verfahren zum herstellen von hochreinen 4a,5,9,10,11,12,-hexahydro-6h-benzofuro(3a,3,2- f)(2) benzazepinen sowie dessen derivaten
CN104592243B (zh) * 2014-12-19 2016-08-24 北京大学 加兰他敏和力克拉敏的不对称合成方法
BG67337B1 (bg) 2018-05-23 2021-06-15 Софарма Ад Метод за получаване на пречистен галантамин хидробромид

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4290862A (en) * 1979-11-14 1981-09-22 Edinen Centar P Chimia Method for the preparation of narwedine-type enones
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine

Also Published As

Publication number Publication date
DK0853624T3 (da) 2001-05-07
PT853624E (pt) 2001-06-29
DE69611796T2 (de) 2001-10-11
WO1997011078A1 (en) 1997-03-27
US6184004B1 (en) 2001-02-06
GR3035752T3 (en) 2001-07-31
AU6996596A (en) 1997-04-09
ATE199153T1 (de) 2001-02-15
CA2230824A1 (en) 1997-03-27
DE69611796D1 (de) 2001-03-22
CA2230824C (en) 2009-09-15
GB9519268D0 (en) 1995-11-22
EP0853624B1 (en) 2001-02-14
AU710980B2 (en) 1999-10-07
EP0853624A1 (en) 1998-07-22

Similar Documents

Publication Publication Date Title
ES2155200T3 (es) Proceso para la preparacion de galantamina y sus derivados.
AR018634A1 (es) Derivados de benzo(b)tiepin-1,1,-dioxido, procedimiento para su preparacion, medicamentos conteniendo estos compuestos, procedimiento para la preparacion de medicamentos y su empleo para la preparacion de medicamentos.
BG104445A (en) NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
ES2055384T3 (es) Compuestos dioxafosforinanos y composiciones poliolefinicas estabilizadas con ellos.
ES2125161B1 (es) Nuevos derivados de 2-(3h)-oxazolona.
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
GR1000467B (el) Μεθοδος παρασκευης τρικυκλικων παραγωγων 3-οξο-προπανονιτριλιου.
DE69014798D1 (de) Thionaphthalen-derivate, verfahren zur herstellung und antiallergisches mittel daraus.
YU46860B (sh) Postupak za proizvodnju derivata pirimidina
DE69619685T2 (de) Galanthaminderivate und verfahren zu deren herstellung
HUT60483A (en) Process for producing homoserine lactones
SI1049686T1 (sl) Intermediati in postopki, uporabni pri semisintezi paklitaksela in analogov
AR004484A1 (es) Nuevas 1,2,3,4-tetrahidro-2-naftalenaminas fenilo-sustituidas en el anillo aromatico, su preparacion, sus aplicaciones terapeuticas y las composicionesfarmaceuticas que las contienen.
ES516361A0 (es) "procedimiento para la preparacion de un diisocianato".
ES502073A0 (es) Metodo de producir lactamas antihipertensoras
AU2971997A (en) Intermediates for oligonucleotide synthesis
ATE133955T1 (de) Acylphosphatester und modifikation von proteinen damit
ES2192090T3 (es) Derivados de calixarenos.
NO20013037L (no) Fremgangsmåte for fremstilling av optisk aktive 1-amino-4- (hydroksymetyl)-cyklopenten-2-en-derivater
ES448907A1 (es) Un procedimiento para la preparacion de derivados de 1,2,3, 4-tetrahidroisoquinoleina.
KR840001154A (ko) 1,2-디티올-3-일리덴 암모늄 유도체의 제조방법
IL78625A0 (en) Furanone derivatives and their preparation
MY106738A (en) Asymmetric synthesis of furo(3,4-c) pyridine derivatives.
DE69616801T2 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
EP0301456A3 (en) Novel (aryl or heteroaromatic methyl)-2,2'-bi-1h-imidazoles

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 853624

Country of ref document: ES